In vivo Fluorescein Isothiocyanate-dextran (FD4) Permeability Assay
pubmed.ncbi.nlm.nih.gov shows its articles on its own site.
Read the article on pubmed.ncbi.nlm.nih.gov ↗Article · Oct 2015 · 1 min read
In brief
In brief
This protocol describes an in vivo assay to measure intestinal barrier function in bioengineered human intestinal tissue derived from pluripotent stem cells and transplanted into mice. By injecting fluorescent FITC-dextran into the intestinal lumen and measuring blood fluorescence over time, researchers can assess epithelial permeability and tight junction integrity in these organoid models.
Written by the GCMD Library team from the article.
Statements in this article
Pluripotent stem cells can be used to develop tissue models of organ systems for studying organ function, physiology, embryology, and pathologic processes.
Human pluripotent stem cells can generate mature, cystic intestinal structures with digestive functions similar to native small intestine when transplanted in vivo.
Intestinal permeability reflects the function of the epithelium and tight junctions to control nutrient intake and prevent pathogen passage.
Gastrointestinal paracellular permeability can be studied by measuring the ability of fluorescein isothiocyanate-dextran (FITC-dextran or FD4) to cross from the lumen into circulation.
Intestinal permeability in bioengineered intestine can be tested by injecting FITC-dextran directly into the lumen and measuring fluorescence in the murine host blood at various time points.
